Cargando…
Taxifolin Prevents Cisplatin Nephrotoxicity by Modulating Nrf2/HO-1 Pathway and Mitigating Oxidative Stress and Inflammation in Mice
Cisplatin (CIS) is an effective chemotherapeutic agent used in the treatment of several malignancies. The clinical use of CIS is associated with adverse effects, including acute kidney injury (AKI). Oxidative stress and inflammation are key events in the development of CIS-induced AKI. This study in...
Autores principales: | Alanezi, Abdulkareem A., Almuqati, Afaf F., Alfwuaires, Manal A., Alasmari, Fawaz, Namazi, Nader I., Althunibat, Osama Y., Mahmoud, Ayman M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692949/ https://www.ncbi.nlm.nih.gov/pubmed/36355481 http://dx.doi.org/10.3390/ph15111310 |
Ejemplares similares
-
Cardioprotective Effect of Taxifolin against Isoproterenol-Induced Cardiac Injury through Decreasing Oxidative Stress, Inflammation, and Cell Death, and Activating Nrf2/HO-1 in Mice
por: Obeidat, Heba M., et al.
Publicado: (2022) -
Hepatoprotective effect of taxifolin on cyclophosphamide-induced oxidative stress, inflammation, and apoptosis in mice: Involvement of Nrf2/HO-1 signaling
por: Althunibat, Osama Y, et al.
Publicado: (2023) -
Formononetin Ameliorates Renal Dysfunction, Oxidative Stress, Inflammation, and Apoptosis and Upregulates Nrf2/HO-1 Signaling in a Rat Model of Gentamicin-Induced Nephrotoxicity
por: Althunibat, Osama Y., et al.
Publicado: (2022) -
Upregulation of Nrf2/HO-1 Signaling and Attenuation of Oxidative Stress, Inflammation, and Cell Death Mediate the Protective Effect of Apigenin against Cyclophosphamide Hepatotoxicity
por: Al-Amarat, Wesam, et al.
Publicado: (2022) -
Punicalagin Protects against the Development of Methotrexate-Induced Hepatotoxicity in Mice via Activating Nrf2 Signaling and Decreasing Oxidative Stress, Inflammation, and Cell Death
por: Al-khawalde, Alayn’ Al-marddyah A., et al.
Publicado: (2022)